Scale Biosciences (Scale Bio), a leader in innovative and scalable single cell analysis solutions, today announced the launch of the “100 Million Cell Challenge,” a global initiative aimed at pushing the boundaries of single-cell genomics research.
Should Older Prostate Cancer Patients Jump Off the Active Surveillance Train?
Come December, as I observe my “pros-mitzvah” — 13 years on active surveillance (AS) for very low-risk prostate cancer — I feel I’m at a